Papers
Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials
BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.619 (Published 21 September 2002) Cite this as: BMJ 2002;325:619Related articles
- This Week In The BMJ Published: 21 September 2002; BMJ 325 doi:10.1136/bmj.325.7365.0
- Editorial Published: 21 September 2002; BMJ 325 doi:10.1136/bmj.325.7365.607
- Paper Published: 21 September 2002; BMJ 325 doi:10.1136/bmj.325.7365.624
- Letter Published: 08 February 2003; BMJ 326 doi:10.1136/bmj.326.7384.334
- Letter Published: 09 November 2006; BMJ 333 doi:10.1136/bmj.39024.372662.1F
- Letter Published: 16 November 2006; BMJ 333 doi:10.1136/bmj.39030.732917.3A
- Letter Published: 15 December 2005; BMJ 331 doi:10.1136/bmj.331.7530.1474-b
See more
- Zika related microcephaly may appear after birth, study findsBMJ November 23, 2016, 355 i6333; DOI: https://doi.org/10.1136/bmj.i6333
- NHS spent 8% more on medicines last yearBMJ November 23, 2016, 355 i6320; DOI: https://doi.org/10.1136/bmj.i6320
- Supervised physiotherapy for mild or moderate ankle sprainBMJ November 16, 2016, 355 i5984; DOI: https://doi.org/10.1136/bmj.i5984
- US adults are more likely to have poor health than those in 10 similar countries, survey findsBMJ November 16, 2016, 355 i6174; DOI: https://doi.org/10.1136/bmj.i6174
- Chronic insomnia: diagnosis and non-pharmacological managementBMJ November 16, 2016, 355 i5819; DOI: https://doi.org/10.1136/bmj.i5819
Cited by...
- Pulsed electromagnetic fields for the management of knee osteoarthritis: multicentre, randomised, controlled, non-inferiority trial protocol
- Effectiveness and safety of bee venom pharmacopuncture for rheumatoid arthritis: a systematic review protocol
- Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations
- Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial
- Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial
- Treatment of Osteoarthritis with Continuous Versus Intermittent Celecoxib
- The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
- EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
- Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
- Approach to managing musculoskeletal pain: Acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?
- Authors' reply on Cochrane reviews v industry supported meta-analyses
- Word limits best explain failings of industry supported meta-analyses
- Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs.
- COX-2 inhibitors and the heart: are all coxibs the same?
- ASAS/EULAR recommendations for the management of ankylosing spondylitis
- Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
- A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations * Commentary
- Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option
- EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
- Taking stock of coxibs
- Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials
- Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib
- The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review
- Assessing the benefit-harm balance at the bedside
- Beyond the evidence
- Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs
- New dogmas or old?
- Balancing benefits and harms in health care
- Osteoarthritis
- Review: celecoxib is as effective as other NSAIDs and leads to fewer gastrointestinal adverse effects
- Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis
- Celecoxib: Equally Efficacious, Less GI Toxic Than Other NSAIDs
- Celecoxib: Equally Efficacious, Less GI Toxic Than Other NSAIDs
- Efficacy and safety of COX 2 inhibitors